| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:Osocimab(anti-Factor XI)
CAS:2056878-75-0
Purity:Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human I Package:100μg Remarks:K13688
|
| Company Name: |
ShangHai Biochempartner Co.,Ltd
|
| Tel: |
177-54423994 17754423994 |
| Email: |
2853530910@QQ.com |
| Products Intro: |
Product Name:Osocimab
CAS:2056878-75-0
Purity:95% Package:100ug;500ug;1mg
|
Osocimab manufacturers
- Osocimab
-
- $835.00 / 10mg
-
2025-09-11
- CAS:2056878-75-0
- Min. Order:
- Purity: > 95%
- Supply Ability: 10g
|
| | Osocimab Basic information |
| Product Name: | Osocimab | | Synonyms: | Osocimab;Research Grade Osocimab (DHC04201);BAY 1213790;Research Grade Osocimab;Osocimab?(anti-Factor XI) | | CAS: | 2056878-75-0 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Osocimab Structure]() |
| | Osocimab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Osocimab Usage And Synthesis |
| Uses | Osocimab (BAY 1213790), an anti-FXIa antibody (Ki=2.4 nM; EC50=0.2 nM). FXI inhibition may reduce the risk of thrombosis. Osocimab inhibits thrombin generation, and prolongs activated partial thromboplastin time. Osocimab exhibits anticoagulant effects[1]. | | References | [1] Schaefer M, et al. Allosteric Inhibition as a New Mode of Action for BAY 1213790, a Neutralizing Antibody Targeting the Activated Form of Coagulation Factor XI. J Mol Biol. 2019 Dec 6;431(24):4817-4833. DOI:10.1016/j.jmb.2019.09.008 |
| | Osocimab Preparation Products And Raw materials |
|